All Day Rhinitic Condition Treatment Regimen
First Claim
15. A method of formulating a therapeutic regimen for treating rhinitis, comprising:
- a) producing a first pharmaceutical dosage form that includes a therapeutically effective amount of a first antihistamine and a therapeutically-effective amount of an anticholinergic agent, and a second pharmaceutical dosage form comprising a therapeutically-effective amount of a second antihistamine, and a therapeutically effective amount of the anticholinergic agent,wherein the first and second antihistamines are either different antihistamines, or different dosages of the same antihistamine, and wherein one of the first and second dosage forms is a daytime formulation, and the other is a nighttime formulation,b) providing the dosage forms in packaging that with indicia that distinguishes the daytime formulation from the nighttime formulation, andc) providing instructions for using the treatment regimen so as to administer the first pharmaceutical dosage form during the day, and the second pharmaceutical dosage form during the evening.
2 Assignments
0 Petitions
Accused Products
Abstract
A therapeutic regimen is disclosed. The regimen includes a first pharmaceutical dosage form comprising a first therapeutically effective amount of a first antihistamine and an anticholinergic agent; and a second pharmaceutical dosage form comprising a therapeutically effective amount of a second antihistamine and an anticholinergic agent. The second antihistamine either has greater H1 receptor activity or greater sedative effect than the first antihistamine, or is a different dose of the same antihistamine. The regimen comprises indicia for distinguishing between the first and second pharmaceutical dosage forms, wherein one dosage form is for daytime administration and the other is for nighttime administration. The regimen is placed in a prepackaged dispenser prefilled with the pharmaceutical dosage forms and comprising the indicia.
-
Citations
41 Claims
-
15. A method of formulating a therapeutic regimen for treating rhinitis, comprising:
-
a) producing a first pharmaceutical dosage form that includes a therapeutically effective amount of a first antihistamine and a therapeutically-effective amount of an anticholinergic agent, and a second pharmaceutical dosage form comprising a therapeutically-effective amount of a second antihistamine, and a therapeutically effective amount of the anticholinergic agent, wherein the first and second antihistamines are either different antihistamines, or different dosages of the same antihistamine, and wherein one of the first and second dosage forms is a daytime formulation, and the other is a nighttime formulation, b) providing the dosage forms in packaging that with indicia that distinguishes the daytime formulation from the nighttime formulation, and c) providing instructions for using the treatment regimen so as to administer the first pharmaceutical dosage form during the day, and the second pharmaceutical dosage form during the evening. - View Dependent Claims (16, 17, 18, 19, 20)
-
-
21. A therapeutic regimen for treating rhinitis, comprising, in a single dosage form:
-
a) a daytime formulation comprising an anticholinergic agent and an antihistamine, and b) a nighttime formulation comprising an anticholinergic agent and an antihistamine, wherein the daytime formulation and nighttime formulation either include different antihistamines, or include different dosages of the same antihistamine, and wherein the dosage form provides for sustained release, over an initial period, of the daytime formulation, and sustained release, delayed until after the initial period, of the nighttime formulation, or, alternatively, sustained release, over an initial period, of the nighttime formulation, and sustained release, delayed until after the initial period, of the daytime formulation. - View Dependent Claims (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)
-
-
22-1. The therapeutic regimen of claim 21, wherein the first antihistamine and the second antihistamine are different dosages of the same antihistamine.
-
40. A method of formulating a therapeutic regimen for treating rhinitis, comprising:
-
(a) producing in a single dose form, a daytime formulation comprising an anticholinergic agent and an antihistamine, and, a nighttime formulation comprising an anticholinergic agent and an antihistamine, wherein the daytime formulation and nighttime formulation either include different antihistamines, or include different dosages of the same antihistamine, and wherein the dosage form provides for release, over an initial period, of the daytime formulation, and release, delayed until after the initial period, of the nighttime formulation, or, alternatively, wherein the dosage form provides for release, over an initial period, of the nighttime formulation, and release, delayed until after the initial period, of the daytime formulation. - View Dependent Claims (41)
-
Specification